Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 25, Issue 2, Pages 107-112
http://dx.doi.org/10.1155/2014/537948
Original Articles

Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010

Shiona K Glass-Kaastra,1 Rita Finley,1 Jim Hutchinson,2 David M Patrick,3,4 Karl Weiss,5 and John Conly6,7,8

1Public Health Agency of Canada, Centre for Food-borne, Environmental and Zoonotic Infectious Diseases, Guelph, Ontario, Canada
2Division of Medical Microbiology, Island Medical Program, University of British Columbia, Vancouver, British Columbia, Canada
3British Columbia Centre for Disease Control, University of British Columbia, Vancouver, British Columbia, Canada
4School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
5Department of Infectious Diseases and Microbiology, University of Montreal, Hôpital Maisonneuve-Rosemont, Montreal, Canada
6Department of Medicine, University of Calgary, Calgary, Alberta, Canada
7Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada
8Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada

Copyright © 2014 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Shiona K Glass-Kaastra, Rita Finley, Jim Hutchinson, David M Patrick, Karl Weiss, and John Conly, “Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 25, no. 2, pp. 107-112, 2014. https://doi.org/10.1155/2014/537948.